These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 11522132)

  • 1. Do national medicinal drug policies and essential drug programs improve drug use?: a review of experiences in developing countries.
    Ratanawijitrasin S; Soumerai SB; Weerasuriya K
    Soc Sci Med; 2001 Oct; 53(7):831-44. PubMed ID: 11522132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European healthcare policies for controlling drug expenditure.
    Ess SM; Schneeweiss S; Szucs TD
    Pharmacoeconomics; 2003; 21(2):89-103. PubMed ID: 12515571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new approach to gathering pharmaceutical market data to support policy implementation and access to medicines: as demonstrated by malaria medicines in Zambia.
    Coghlan R; Stephens P; Mwale B; Siyanga M
    Malar J; 2018 Nov; 17(1):444. PubMed ID: 30497504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical policies: effects of cap and co-payment on rational drug use.
    Austvoll-Dahlgren A; Aaserud M; Vist G; Ramsay C; Oxman AD; Sturm H; Kösters JP; Vernby A
    Cochrane Database Syst Rev; 2008 Jan; (1):CD007017. PubMed ID: 18254125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fall and rise of cost sharing in Kenya: the impact of phased implementation.
    Collins D; Quick JD; Musau SN; Kraushaar K; Hussein IM
    Health Policy Plan; 1996 Mar; 11(1):52-63. PubMed ID: 10155878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relevance of systematic reviews on pharmaceutical policy to low- and middle-income countries.
    Gray AL; Suleman F
    Int J Clin Pharm; 2015 Oct; 37(5):717-25. PubMed ID: 26177819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International experience in controlling pharmaceutical expenditure: influencing patients and providers and regulating industry - a systematic review.
    Lee IH; Bloor K; Hewitt C; Maynard A
    J Health Serv Res Policy; 2015 Jan; 20(1):52-9. PubMed ID: 25092883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An analysis of the pharmaceuticals market in Vietnam].
    Simonet D
    Sante; 2001; 11(3):155-60. PubMed ID: 11641078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient access to medicines in two countries with similar health systems and differing medicines policies: Implications from a comprehensive literature review.
    Babar ZU; Gammie T; Seyfoddin A; Hasan SS; Curley LE
    Res Social Adm Pharm; 2019 Mar; 15(3):231-243. PubMed ID: 29678413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.
    Suleman S; Woliyi A; Woldemichael K; Tushune K; Duchateau L; Degroote A; Vancauwenberghe R; Bracke N; De Spiegeleer B
    Ethiop J Health Sci; 2016 May; 26(3):259-76. PubMed ID: 27358547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health professionals' experience of teamwork education in acute hospital settings: a systematic review of qualitative literature.
    Eddy K; Jordan Z; Stephenson M
    JBI Database System Rev Implement Rep; 2016 Apr; 14(4):96-137. PubMed ID: 27532314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A critical analysis of studies of state drug reimbursement policies: research in need of discipline.
    Soumerai SB; Ross-Degnan D; Fortess EE; Abelson J
    Milbank Q; 1993; 71(2):217-52. PubMed ID: 8510601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Student and educator experiences of maternal-child simulation-based learning: a systematic review of qualitative evidence protocol.
    MacKinnon K; Marcellus L; Rivers J; Gordon C; Ryan M; Butcher D
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):14-26. PubMed ID: 26447004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive taxonomy and worldwide trends in pharmaceutical policies in relation to country income status.
    Maniadakis N; Kourlaba G; Shen J; Holtorf A
    BMC Health Serv Res; 2017 May; 17(1):371. PubMed ID: 28545440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of internet-based e-learning on clinician behavior and patient outcomes: a systematic review protocol.
    Sinclair P; Kable A; Levett-Jones T
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):52-64. PubMed ID: 26447007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do international model drug control laws provide for drug availability?
    University of Wisconsin Pain & Policy Studies Group
    J Pain Palliat Care Pharmacother; 2009; 23(2):145-52. PubMed ID: 19492215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential drugs in the Gambia.
    Jallow MT
    World Health Forum; 1993; 14(2):136-9. PubMed ID: 8185753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies.
    Hamilton WL; Doyle C; Halliwell-Ewen M; Lambert G
    Health Policy Plan; 2016 Dec; 31(10):1448-1466. PubMed ID: 27311827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National tuberculosis programme review: experience over the period 1990-95.
    Pio A; Luelmo F; Kumaresan J; Spinaci S
    Bull World Health Organ; 1997; 75(6):569-81. PubMed ID: 9509630
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.